Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study-Reference-Cited by-同舟云学术

Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study

Published:2016-01-02 Issue:1 Volume:17 Page:17-28
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Teófilo Eugénio,Rocha-Pereira Nuno,Kuhlmann Birger,Antela Antonio,Knechten Heribert,Santos Jesús,Jiménez-Expósito Maria Jesús,

Funder

Bristol-Myers Squibb (France)

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

https://www.tandfonline.com/doi/pdf/10.1080/15284336.2015.1112494

Reference24 articles.

1. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

2. The Importance of Potency and Durability in HIV Patient Antiretroviral Therapy Preferences: A Telephone Survey

3. Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services; 2014. http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf. Accessed March 23, 2015.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperbilirubinemia during Atazanavir/Ritonavir Treatment in HIV-infected Patients at Vajira Hospital, a Tertiary Hospital in Thailand;2023-06-26

2. Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistat;HIV Research & Clinical Practice;2019-05-04

3. Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study);Journal of Antimicrobial Chemotherapy;2018-04-27